Latest News
BrightFocus honors the life of Donald L. Price, MD.
A BrightFocus-funded research team has some eye-opening news: They’ve used artificial intelligence to develop a model that could one day detect Alzheimer’s disease through photographs of the eye, which could lead to earlier diagnosis and treatment.
BrightFocus Foundation will support a new five-year research initiative in Canada that will study the aging brain and identify how to reduce the risks of dementia and other forms of cognitive impairment.
Register for our new Zoom in on Dementia & Alzheimer’s program, a free, monthly, virtual discussion series featuring medical experts.
Researchers have identified a new gene region in people of African descent that reduces Alzheimer's disease risk—highlighting the importance of diversity and inclusion of all populations in research.
A BrightFocus Foundation-funded study found that even moderate alcohol use can cause changes in the brain that may accelerate Alzheimer’s disease, shedding new light on a possible modifiable risk factor for dementia.
BrightFocus-funded research offers new evidence of the importance of tau in the prediction of Alzheimer’s disease which could lead to ways to delay—or even stop—the disease from progressing.
Read about some of the ways BrightFocus Foundation is taking action to reduce health disparities and inequities among underrepresented communities and better meet the precise health needs of these populations.
Led by a BrightFocus grantee, a research team has developed a new marker of Alzheimer’s disease neurodegeneration in the blood, paving the way for a more accurate blood test to detect Alzheimer’s disease.
Using a molecule found in green tea, an Alzheimer's Disease Research-funded team of biochemists has identified new molecules that can destroy protein tangles in the brain linked to Alzheimer's and related brain diseases.
